WALTHAM, Mass.--(BUSINESS WIRE)--Aug 23, 2018--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 16 th annual Morgan Stanley Global Healthcare Conference on Friday, September 14, 2018 at 11:40 a.m. ET at the Grand Hyatt New York in New York City.

Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic priorities.

A live audio webcast of the presentation will also be available on the Investor s section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.

About PerkinElmer PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005094/en/

CONTACT: PerkinElmer, Inc.

Investor Relations

Tommy J. Thomas, 781-663-5889

tommy.thomas@perkinelmer.com

or

Media Relations

Brian Willinsky, 781-663-5728

brian.willinsky@perkinelmer.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL

SOURCE: PerkinElmer, Inc.

Copyright Business Wire 2018.

PUB: 08/23/2018 04:15 PM/DISC: 08/23/2018 04:15 PM

http://www.businesswire.com/news/home/20180823005094/en